Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.

Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37313140

about

Urinary Markers of Tubular Injury in Early Diabetic Nephropathy TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients.Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling.Urinary neutrophil gelatinase-associated lipocalin is an early predictor of acute kidney injury in premature infants Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes.Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome.Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes.Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus.

P2860

Q26746921-E36BFBC7-88E2-4C2F-BCB8-F92E4C3461C2 Q34838338-C502017F-9A71-456E-935D-98035ECBC2B1 Q34976710-007961F0-0421-4E2E-BA2A-902F6508CB50 Q36386660-13F925BB-A464-440C-BB20-2D044AE13DD0 Q37512638-199DD353-0799-4A12-8645-C2600E8AD537 Q37675571-58F18F70-17EC-44FB-8CF0-4317B48C9C74 Q38758052-B89716B5-B94F-4118-923A-083D7F78589D Q41418717-F0915341-E586-4E95-9D2D-7433B9D48055 Q41463382-C80CCE20-FDEE-4787-94DE-EFA8F0DC65BE Q41980284-F995E8FB-316C-4751-80F6-3F0A510322E2 Q42203151-08B3CD85-35E3-4598-92F9-0C11DEEF3322 Q47136591-0462EED9-FC81-4C54-AC79-6A3731B67712 Q55084614-506631F7-9BB9-4919-992C-B153B5AB9DF6

P2860

Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37313140

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@en

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@nl

type

label

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@en

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@nl

prefLabel

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@en

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@nl

P1433

Q37313140-ADDB4697-4A96-43D0-8660-F2DDFE761F9A

P1476

Q37313140-0322C5D1-A21E-4632-BF02-AF2AF1A60588

P2093

Q37313140-009E7FC6-D5CA-4F5E-9313-E54A814AD9B9

Q37313140-38A03530-DCAD-40EE-A6FC-60AD275DC153

Q37313140-7419050D-9DA4-43FC-896A-89DE856A103A

Q37313140-966BECD1-8832-41D4-8C4E-D402DD511D61

Q37313140-AB2B2F86-96BB-4170-B6FA-0EC4BEDB5949

Q37313140-BFCF2DA2-F2C3-4084-9B0C-44C075973D54

Q37313140-F097ED62-EF87-4444-8787-F23760970619

P2860

Q37313140-0A8A24F2-2E63-496D-A77C-69B0AB847BD9

Q37313140-256223D3-D257-4EEC-A4E7-B3685F7CF6A0

Q37313140-2FC07E9D-3ECC-4405-BB98-589BA453AE86

Q37313140-3333F27D-52D9-4990-81A4-0A926BB68FD4

Q37313140-3377738E-E63C-4A72-94F3-E86979DFB6E0

Q37313140-43B06BB2-0DD3-430C-BAC1-E3009BCB0E12

Q37313140-4B6A0371-0A48-40C3-ACBD-2734E95995B6

Q37313140-520601B7-2940-4F5C-8AA6-90654E4EC0D2

Q37313140-5B6B9870-1302-46B2-AC35-12797907A09F

Q37313140-6433CE37-6E25-4184-8907-51F8B93A9AEB

P304

Q37313140-B8B5181E-8E4C-42BE-BC4D-7A3FCF547BFB

P31

Q37313140-06DBE2E7-9113-4257-8DE3-33A8C2B5E783

P356

Q37313140-F1E46565-535F-43BD-9FD0-2CA85B1588AE

P433

Q37313140-A6D79608-1BDE-4C01-B241-7700FA1B654F

P478

Q37313140-C58049A3-E24E-442B-9F80-85C27609E411

P577

Q37313140-B10EE160-7EC6-4124-B5ED-F52B8F0F2A6B

P5875

Q37313140-17E31DE7-769B-42E6-ACB8-8E2A6402B947

P698

Q37313140-96405912-D7AA-46DD-8514-3D205C64F4FF

P921

Q37313140-6662DA8D-C596-403B-88D1-8FB2330FB7DB

Q37313140-E60B3F4E-C2C0-4FFF-AC67-E684DFC5D71E

P932

Q37313140-C946C0DA-2491-41E0-9626-FCDA41607A73

P356

P1433

Experimental and Therapeutic Medicine

P1476

Urinary TNF-α and NGAL are cor ...... patients with type 2 diabetes.

@en

P2093

Chunling Zhu

http://www.w3.org/2001/XMLSchema#string

Jian Wu

http://www.w3.org/2001/XMLSchema#string

Kan Lu

http://www.w3.org/2001/XMLSchema#string

Rui Wang

http://www.w3.org/2001/XMLSchema#string

Xiaohong Shao

http://www.w3.org/2001/XMLSchema#string

Xin Xie

http://www.w3.org/2001/XMLSchema#string

Yaqing Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery

Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study

Potential risk factors for diabetic neuropathy: a case control study

Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

Diabetic nephropathy: diagnosis, prevention, and treatment.

Standards of medical care in diabetes--2011.

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.

Urine proteomics: the present and future of measuring urinary protein components in disease

Urinary markers of glomerular injury in diabetic nephropathy

P304

1482-1488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2013.1315

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258704010

http://www.w3.org/2001/XMLSchema#string

P698

24250725

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3829713

http://www.w3.org/2001/XMLSchema#string